Browsing by Author Campistol, Josep M.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)Citation
2009Chronic allograft nephropathy - a clinical syndrome: Early detection and the potential role of proliferation signal inhibitorsChapman, Jeremy; Øyen, Ole; Boletis, Ioannis; Campistol, Josep M.; Dantal, Jacques; de Fijter, J. W.; et al, various; Hertig, Alexandre; Neumayer, Hans-Hellmut; Pascual, Julio; Pohanka, Erich; RUIZ, JUAN CARLOS; Western Clinical School: Westmead Millennium InstituteChronic allograft nephropathy - a clinical syndrome: Early detection and the potential role of proliferation signal inhibitors, Clinical Transplantation, vol.23, 6,pp 769-777
2005Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation.Chapman, Jeremy; Brault, Yves; BURKE, JAMES T; Campistol, Josep M.; Grinyo, Josep M.; Hartmann, Anders; Kreis, Henri; Lawen, Joseph; MOTA, ALFREDO; Neylan, John F.; OBERBAUER, RAINER; Pinto, Jose R.; Russ, Graeme; Segoloni, Giuseppe; Stallone, Giovanni; Western Clinical School: Westmead Millennium InstituteEarly cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation., Transplant International, vol.18,(1),2005,pp 22-28
2006Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation.Eris, Josette; Campistol, Josep M.; Claesson, Kerstin; et, al; Friend, Peter; Hutchison, Brian; Morales, Jose M.; Oberbauer, Rainer; Rostaing, Lionel; Russ, Graeme; Stallone, Giovanni; Concord Clinical School: MedicineSirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation., Journal of the American Society of Nephrology, vol.17,(2),2006,pp 581-589
2005Sirolimus-Based Therapy With or Without Cyclosporine: Long-Term Follow-up in Renal Transplant PatientsEris, Josette; Andres, A.; Campistol, Josep M.; Castaing, N.; et, al; Grinyo, J. M.; Kreis, Henri; Morales, Jose M.; Mourad, G.; Nanni, G.; Schena, Francesco Paolo; Concord Clinical School: MedicineSirolimus-Based Therapy With or Without Cyclosporine: Long-Term Follow-up in Renal Transplant Patients, Transplantation Proceedings 2005, vol.37,(2),2005,pp 693-696
2013Sotastaurin in Calcineurin Inhibitor-Free Regimen Using Everolimus in De Novo Kidney Transplant RecipientsEris, Josette; Budde, Klemens; Campistol, Josep M.; Gopalakrishnan, U; Hartmann, A; Kho, M.M.L; Klupp, J; Krishnan, I; Rostaing, L; Russ, G; Tedesco-Silva, Helio; Vitko, S; Concord Clinical School: MedicineSotastaurin in Calcineurin Inhibitor-Free Regimen Using Everolimus in De Novo Kidney Transplant Recipients, American Journal of Transplantation, vol.13, 7, 2013,pp 1757-1768
2007Use of proliferation signal inhibitors in the management of post-transplant malignancies - clinical guidanceChapman, Jeremy; Albanell, Joan; Arns, Wolfgang; Boletis, Ioannis; Campistol, Josep M.; Dantal, Jacques; de Fijter, J. W.; Mortensen, Svend Aage; Neumayer, Hans-Hellmut; Oyen, Ole; Pascual, Julio; Pohanka, Erich; Schena, Francesco Paolo; Seron, Daniel; Sparacino, Vito; Western Clinical School: Westmead Millennium InstituteUse of proliferation signal inhibitors in the management of post-transplant malignancies - clinical guidance, Nephrology Dialysis Transplantation (2005), vol.22,(Supp1),2007,pp i36-i41